Investing today,
for the long term
PP-UNP-USA-4598 © 2024 Pfizer Inc. All rights reserved. September 2024
Reference: 1. The United States Pharmacopeia. USP Annual Drug Shortages Report: Economic factors underpin 2023 shortages. Published June 2024. Accessed
August 26, 2024. https://go.usp.org/l/323321/2024-05-31/92zsjg/323321/1717187146zgOpt4vW/GEA_GC_056R_MSM_Report_2024_05_FINAL.pdf
Visit us at ASHP Midyear in New Orleans, at Booth #70
Scan here to read
Pfizer's position
*From 2019 to 2023.
In the last 5 years,* primarily due to economic factors, the number of drug shortages
has increased. In 2023, over 90% of sterile injectable products were at severe risk for
shortages. Product discontinuations increased by 40% from 2022 to 2023, and the
duration of shortages increased by 50%.
1
Pfizer Hospital is working to provide a reliable, high-quality supply of sterile
injectables by expanding capacity, increasing inventory, and creating redundancies.
Be part of the long-term supply solution
• Join us in supporting long-term supply solutions
• Comply with existing contracts and purchase products that return to market
• Purchase from manufacturers like Pfizer that invest in supply resiliency
